Glutathione-responsive nanoscale MOFs for effective intracellular delivery of the anticancer drug 6-mercaptopurine.
Chem Commun (Camb)
; 56(47): 6448-6451, 2020 Jun 14.
Article
em En
| MEDLINE
| ID: mdl-32393947
ABSTRACT
A glutathione-triggered drug delivery system (DDS) based on nanoscale metal-organic frameworks (NMOFs) is developed, which features an intracellular redox-responsive release of an anticancer drug. Compared to normal cells, the current NMOF-based DDS has 3-fold higher cytotoxicity to cancer cells, prefiguring its great potential for selective cancer therapy.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sistemas de Liberação de Medicamentos
/
Nanopartículas
/
Estruturas Metalorgânicas
/
Glutationa
/
Mercaptopurina
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article